Hulo, Pauline
Deshayes, Sophie
Fresquet, Judith
Chéné, Anne-Laure
Blandin, Stéphanie
Boisgerault, Nicolas
Fonteneau, Jean-François
Treps, Lucas
Denis, Marc G
Bennouna, Jaafar
Fradin, Delphine
Pons-Tostivint, Elvire
Blanquart, Christophe
Funding for this research was provided by:
Ligue Contre le Cancer
Institut de Recherche en Santé Respiratoire des Pays de la Loire
Article History
Received: 11 October 2023
Accepted: 25 March 2024
First Online: 5 April 2024
Declarations
:
: ADCA117 lung cancer cell line was established from the pleural fluid of a NSCLC cancer patient. ADCA117 cell line belongs to a biocollection of samples, from patients from Nantes University Hospital, collected in accordance with the standards established by the Declaration of Helsinki. Recruited patients had received no prior anticancer therapies and gave signed informed consent. All the collected samples and the associated clinical information were registered in a database (DC-2017-2987) validated by the French Ministry of Research. Our study was approved by local independent ethical committee (CPP Ouest-IV-Nantes).
: Not applicable.
: The authors declare no competing interests.